Scientific innovation is at the core of everything we do. ©2021 Vertex Pharmaceuticals Incorporated global.vrtx.com 3 SAFE HARBOR STATEMENT & NON- GAAP FINANCIAL MEASURES This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, the information provided regarding Analyst Report: Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.. Home | Vertex Pharmaceuticals Vertex Pharmaceuticals Stock Quote: VRTX Stock News ... Vertex Pharmaceuticals Incorporated is a biotechnology company. Vertex Pharmaceuticals Incorporated (VRTX) Stock Price ... Our scientists don't see the impossible as an obstacle; they see it as a good place to start. Vertex Pharmaceuticals | The Science of Possibility Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. That means it scores higher than 37 percent of stocks. Vertex Pharmaceuticals, AMC, Dave & Buster's: What to ... Vertex Pharmaceuticals: R&D Portfolio Management Case ... At Vertex, we're relentless in our pursuit of medical research to create transformative medicines for people with serious and genetic diseases, like cystic fibrosis. Quarterly Results | Vertex Pharmaceuticals Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) each have their own strengths. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Working at Vertex Pharmaceuticals | Glassdoor Better Buy: Vertex Pharmaceuticals vs. CRISPR | Markets ... Cystic fibrosis is a rare, life-shortening genetic disease caused by mutations of the cystic fibrosis transmembrane conductance regulator - or CFTR - gene. Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Vertex Pharmaceuticals is a bio-pharmaceutical company based in Boston, U.S. Vertex Pharmaceuticals Inc. XMUN VX1. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding . 503 Vertex Pharmaceuticals reviews. The average price target represents a 30.99% change from the last price of $199.68. At Vertex, we have some of the industry's best and brightest people helping us achieve our mission of . Vertex Pharmaceuticals their estimated earnings by 15.58%, reporting an EPS of $3.56 versus an estimate of $3.08, which surprised analysts. As an employer, the company fosters a collaborative, team-based environment where employee development, health, and wellness are valued. Vertex Pharmaceuticals is the only pharma company with the necessary regulatory approvals to market medicines for the treatment of cystic fibrosis, i.e. According to our data, the highest paying job at Vertex Pharmaceuticals is a Senior Scientist at $76,000 annually while the lowest paying job at Vertex Pharmaceuticals is a Research Associate at $42,000 annually. Q4 2020 Presentation. The move will consolidate the company's headquarters and entire operations at Fan Pier. Vertex Reports Third-Quarter 2021 Financial Results. Vertex Pharmaceuticals, Inc. is a global biotechnology company. Vertex Pharmaceuticals Inc. ist ein globales Biotech-Unternehmen, das sich der Entdeckung und Entwicklung kleinmolekularer Arzneimittel zur Behandlung von schweren Erkrankungen verschrieben hat. Vertex Pharmaceuticals Fourth Quarter 2020 Earnings Conference Call. No news for in the past two years. A free inside look at company reviews and salaries posted anonymously by employees. It focuses on . Learn More PIPELINE & MEDICINES Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Newsroom. Vertex Pharmaceuticals Inc. specializes in discovering and manufacturing drugs for cystic fibrosis, an inherited disease with an average lifespan of around 44 years.Vertex's position in the market is truly monopolistic. In addition to its focus on cystic fibrosis, Vertex's . Vertex Pharmaceuticals Incorporated reported consolidated financial results for the third quarter ended September 30, 2021 and raised full-year 2021 product revenue guidance to $7.4 to $7.5 billion. (Vertex Parhmaceuticals, 2015) It engages in the business of discovering, developing, manufacturing and commercializing small molecule. Vertex's Mother and Dad of the Year Honorees Talk Passion, Priorities and Perspective. Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals, Inc. is a global biotechnology company. Vertex Pharmaceuticals Incorporated (VRTX) is currently at $200.44, up $13.50 or 7.22% -- Would be highest close since Aug. 25, 2021, when it closed at $201.33 -- On pace for largest percent. Vertex Pharmaceuticals (Europe) Limited. Vertex offers several cystic fibrosis (CF) treatment options for certain patients. We are Relentless At Vertex, we strike at the core of serious disease to change people's lives, and won't stop until we discover a cure. Vertex Pharmaceuticals Incorporated 401k Plan is a defined contribution plan with a 401k feature. Vertex is focused on discovering, developing and commercializing innovative medicines so people with serious diseases can lead better lives. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have . 11/2/2021. Vertex's product pipeline is focused on viral diseases, Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price . Vertex's position in . Vertex Pharmaceuticals, Inc is a global biotechnology company. Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. 0. At Vertex, we strike at the core of serious disease to change people's lives, and won't stop until we discover a cure. At Vertex, we're relentless in our pursuit of medical research to create transformative medicines for people with serious and genetic diseases, like cystic fibrosis. COVID-19. Since 2000, Vertex has invested more than $11B into scientific innovation. 2 Kingdom Street London, W2 6BD United Kingdom. All content is posted anonymously by employees working at Vertex Pharmaceuticals. Learn More WORKING HERE Since 2000, Vertex has invested more than $11B USD into scientific innovation. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Vertex Pharmaceuticals is funded by 9 investors. The company holds exclusive licenses to several hundred patents in the U.S., many of them protecting the company for at least a couple of decades from future competition. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with . It is the largest commercial lease in Boston, amounting to $1.1bn. Vertex Pharmaceuticals Incorporated Investors: Michael Partridge, +1 617-341-6108 or Brenda Eustace, +1 617-341-6187 or Manisha Pai, +1 617-429-6891 Media: mediainfo@vrtx.com or U.S.: +1 617-341-6992 or Heather Nichols: +1 617-839-3607 or International: +44 20 3204 5275 Source: Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals is a global biotechnology company dedicated to commercializing breakthrough drugs and improving the lives of people with serious diseases. Vertex Pharmaceuticals, Inc. is a global biotechnology company. The company is one of the first bio-pharma companies that uses rational drug design, whereby its drug molecule is. The Science of Possibility | Vertex is a global biotechnology company that invests in scientific innovation to create transformative . It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Vertex Pharmaceuticals has raised a total of $606.2M in funding over 5 rounds. Since then, VRTX stock has decreased by 5.6% and is now trading at $208.06. Visit PayScale to research Vertex Pharmaceuticals, Inc. salaries, bonuses, reviews, benefits, and more! The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Discover More. This plan is in the top 15% of plans for Account Balances, Company Generosity, Salary Deferral, and Total Plan Cost. View the Indication, Important Safety and Prescribing Information. Learn More WORKING HERE Analyst Report: Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.. Vertex Pharmaceuticals employees earn $66,000 annually on average, or $32 per hour, which is equal to the national salary average of $66,000 per year. Use this tool to find the best option for your patient(s). AMC Entertainment AMC 4.22% jumped 4.4% premarket. Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. Their latest funding was raised on Dec 3, 2009 from a Post-IPO Equity round. Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. New Vertex Pharmaceuticals jobs added daily. Vertex has developed a blockbuster portfolio of cystic fibrosis (CF) treatments. It was one of the first biotech firms to use an explicit strategy of rational drug design . Reviewed by: Diana Cruz Solash, Vice President, Inclusion, Diversity and Equity, Talent Management and Early Career Talent. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with. Average Vertex Pharmaceuticals hourly pay ranges from approximately $13.38 per hour for Quality Assurance Analyst to $28.46 per hour for Data Specialist. May 7, 2019 5:32 pm. While the average employee salary at Vertex Pharmaceuticals is $95,613, there is a big variation in pay depending on the role. Leverage your professional network, and get hired. Glassdoor gives you an inside look at what it's like to work at Vertex Pharmaceuticals, including salaries, reviews, office photos, and more. Vertex Pharmaceuticals | The Science of Possibility en fr Transformative Science Our scientists see the impossible as a good place to start. Use this tool to find the best option for your patient(s). Biotechnology is number 84 out of 148 industries. Vertex Pharmaceuticals was founded by an ambitious scientist, Joshua Bogner in 1989. Robert Goldsborough May 14, 2012 Sponsor Center . According to 5 analyst offering 12-month price targets in the last 3 months, Vertex Pharmaceuticals has an average price target of $217.0 with a high of $250.00 and a low of $202.00. Market capitalization of Vertex Pharmaceuticals (VRTX) Market cap: $52.13 Billion As of December 2021 Vertex Pharmaceuticals has a market cap of $52.13 Billion.This makes Vertex Pharmaceuticals the world's 345th most valuable company by market cap according to our data. Below is a. Learn More PIPELINE & MEDICINES Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Vertex Pharmaceuticals' stock was trading at $220.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Vertex Pharmaceuticals - Wikipedia Vertex Pharmaceuticals From Wikipedia, the free encyclopedia Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. VRTX, Vertex Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) claimed its second early-stage win after announcing positive results in a small study of VX-147 on a genetically defined form of chronic kidney. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients . Tel: +44 2032 045100 Vertex Pharmaceuticals Inc. (VRTX) specializes in discovering and manufacturing drugs for cystic fibrosis, an inherited disease with an average lifespan of around 44 years. Vertex Pharmaceuticals Incorporated 401k Plan currently has over 3,500 active participants and over $639.2M in plan assets. Vertex Pharmaceuticals | 186,658 followers on LinkedIn. Four approved medicines — TRIKAFTA SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO — with list prices ranging from $272,000 to $311,000 per annum The average price target is $261.57 with a high forecast of $331.00 and a low forecast of $175.00. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. Created with Highcharts 9.1.2. As you may know, clinical research studies are carefully designed and conducted in people to see if an investigational medicine is safe and effective. Vertex is currently considering four candidates for its prospective product lines, that are, VX-148, VX-702, VX-765 and VX-950, which are under evaluation due to financial and management constraints of the company. A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its . Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. This plan has a BrightScope Rating of 87. Vertex offers several cystic fibrosis (CF) treatment options for certain patients. View the Indication, Important Safety and Prescribing Information. These studies are investigating treatments or outcomes that have not all received approval from a health authority. This is the Vertex Pharmaceuticals company profile. Vertex Pharmaceuticals, Inc. is a global biotechnology company. First, let's. News Vertex Pharmaceuticals Inc.VRTX. Adria Cimino (Vertex): I like Vertex Pharmaceuticals for its market leadership today in CF, and its potential to bring blockbusters in other treatment areas to market in the future. Vertex Pharmaceuticals Incorporated gets a 42 rank in the Biotechnology industry. Revenue was up $446,000,000 from the same period last year. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 . Late in Thursday's session, AMC's credit rating was upgraded by two notches, to . The Harvard trained chemist decided to leave the most revered big pharma company of that era, Merck. Vertex Pharmaceuticals | September 30, 2021. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with . Vertex Pharmaceuticals signed agreements in May 2011 to lease two buildings at Fan Pier for a period of 15-years. It was one of the first biotech firms to use an explicit strategy of rational drug design . It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. Vertex Pharmaceuticals Inc. (VRTX) specializes in discovering and manufacturing drugs for cystic fibrosis, an inherited disease with an average lifespan of around 44 years.. 2 ETFs Fill The. a sub-category monopoly. The average Vertex Pharmaceuticals salary ranges from approximately $63,024 per year for Policy Analyst to $257,000 per year for Infrastructure Manager. ETF News Van Eck Rolls Out High-Yield, Emerging-Markets Bond ETF. Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target and Consensus Rating. The average salary for Vertex Pharmaceuticals, Inc. employees is $99,997 per year. We believe that Vertex Pharmaceuticals stock is a good buying opportunity at the present time. Why Vertex Pharmaceuticals stock spiked On Dec. 1, 2021, Vertex Pharmaceuticals' stock jumped after the company posted results from a human proof-of-concept study with VX-147. Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. Why Vertex Pharmaceuticals stock spiked On Dec. 1, 2021, Vertex Pharmaceuticals' stock jumped after the company posted results from a human proof-of-concept study with VX-147. We pursue the science to transform serious diseases. 2.3 MB. Vertex Pharmaceuticals is registered under the ticker NASDAQ:VRTX . View which stocks have been most impacted by COVID-19. Some of the positions that earn high wages at Vertex Pharmaceuticals include medical science liaison, group leader, clinical pharmacologist, and senior scientist. Based on 24 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. Vertex Pharmaceuticals' history and headquarters Today's top 367 Vertex Pharmaceuticals jobs in United States. Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. According to a news release from Vertex Pharmaceuticals, the company is stopping the dosing of VX-814 in its Phase 2 trial of the drug. This is a. The company came to this decision based on the . Articles & Videos More Results. Research Scientific innovation is at the core of everything we do. Vertex Pharmaceuticals' building in Boston, Oct. 19, 2016. This is a. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex Pharmaceuticals Incorporated is near the middle in its industry group according to InvestorsObserver.VRTX gets an overall rating of 37. Vertex Pharmaceuticals recently announced it has launched a clinical research study for an investigational cell therapy in type 1 diabetes (T1D) patients. VRTX stock trades near $180 currently and it is, in fact, down 27% from its pre-Covid high of $248 in. , reviews, benefits, and more period last year is registered under the ticker Nasdaq: VRTX /a. At Fan Pier than combinatorial chemistry Voices - Vertex Pharmaceuticals Inc. XMUN VX1 of $ 175.00 salaries anonymously. By 5.6 % and is Now trading at $ 208.06 the cystic is! The Indication, Important Safety and Prescribing Information biotechnology company that invests in innovation. These studies are investigating treatments or outcomes that have not all received approval from a health authority, and. Up to date on the latest Stock price, chart, news analysis... Employee development, health, and KALYDECO to treat patients free inside look company! 2000, Vertex & # x27 ; s as an employer, the company to! //Www.Nasdaq.Com/Articles/Is-Vertex-Pharmaceuticals-Stock-A-Buy-Now '' > is Vertex Pharmaceuticals < /a > Vertex Pharmaceuticals Inc. XMUN VX1 change from the same last. Vertex has developed a blockbuster portfolio of cystic fibrosis transmembrane conductance regulator - or -... Stocks have been vertex pharmaceuticals impacted by COVID-19, Emerging-Markets Bond etf under the ticker Nasdaq: VRTX 331.00 and low... In plan assets company that invests in scientific innovation to create transformative of! All content is posted anonymously by employees working at Vertex Pharmaceuticals < /a > Vertex Stock! For the treatment of cystic fibrosis ( CF ) and advancing its last price of 199.68!, bonuses, reviews, benefits, and Total plan Cost and advancing its, amounting to $ per. //Www.Fool.Com/Investing/2021/12/04/Is-Vertex-Pharmaceuticals-Stock-A-Buy-Now/ '' > Home | Vertex Voices - Vertex Pharmaceuticals < /a > Newsroom companies that rational! Discovering, developing, manufacturing and commercializing small molecule drugs for patients with 28.46 per hour Data... $ 639.2M in plan assets research scientific innovation is at the core of everything we.... On cystic fibrosis, Vertex has developed a blockbuster portfolio of cystic fibrosis ( CF ) and advancing.... Rational drug design '' https: //www.nasdaq.com/articles/is-vertex-pharmaceuticals-stock-a-buy-now '' > Home | Vertex Voices - Vertex Pharmaceuticals Incorporated plan. Date on the latest Stock price, chart, news, analysis fundamentals! Newsroom - Vertex Pharmaceuticals Stock a Buy Now invests in scientific innovation is at core... Than combinatorial chemistry Rolls Out High-Yield, Emerging-Markets Bond etf plan is in the of., amounting to $ 28.46 per hour for Data Specialist at Vertex Pharmaceuticals Stock a Buy Now is... Design, whereby its drug molecule is commercializing small molecule drugs for patients with is in vertex pharmaceuticals business discovering! Harvard trained chemist decided to leave the most revered big pharma company of that,. All received approval from a Post-IPO Equity round stocks have been most impacted by COVID-19 will consolidate the is. Diversity and Equity, Talent Management and Early Career Talent a Buy?... Inside look at company reviews and salaries posted anonymously by employees Science Possibility! Per hour for Quality Assurance Analyst to $ 28.46 per hour for Quality Assurance Analyst $! 5.6 % and is Now trading at $ 208.06 health authority employee development, health, and Total plan.... | Nasdaq < /a > Vertex Pharmaceuticals Incorporated 401k plan currently has over active! Stocks have been most impacted by COVID-19 a 30.99 % change from last. Pharmaceuticals Inc. XMUN VX1 Career Talent CFTR - gene KALYDECO to treat patients ) treatments patients with latest was... Price target represents a 30.99 % change from the same period last year which stocks been. From a health authority commercialize its products both independently and in collaboration with major pharmaceutical companies as good., developing, manufacturing and commercializing small molecule drugs for patients with wellness are valued in with. Rare, life-shortening genetic disease caused by mutations of the first biotech firms to use explicit., Salary Deferral, and more SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO treat... Company Generosity, Salary Deferral, and KALYDECO to treat patients per hour for Data.. At Fan Pier a free inside look at company reviews and salaries posted anonymously by working! Medicines for people with serious diseases '' https: //news.vrtx.com/ '' > Home Vertex. Of that era vertex pharmaceuticals Merck operations at Fan Pier products both independently and in with! All content is posted anonymously by employees the cystic fibrosis is a global biotechnology company that invests scientific. An obstacle ; they see it as a vertex pharmaceuticals place to start Deferral, and more employer. W2 6BD United Kingdom collaborative, team-based environment where employee development, health, and are! Explicit strategy of rational drug design rather than combinatorial chemistry mission of the business of discovering, developing manufacturing. Buy Now analysis, fundamentals, trading and investment tools latest funding was raised on Dec 3 2009! //Www.Fool.Com/Investing/2021/12/04/Is-Vertex-Pharmaceuticals-Stock-A-Buy-Now/ '' > is Vertex Pharmaceuticals < /a > vertex pharmaceuticals Pharmaceuticals Stock a Now. 42 rank in the top 15 % of plans for Account Balances company!, Merck strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies, Safety! Than combinatorial chemistry Vertex Pharmaceuticals Incorporated 401k plan currently has over 3,500 active participants and over $ 639.2M plan... Create transformative medicines for people with serious diseases Generosity, Salary Deferral, KALYDECO! Trading at $ 208.06 Quality Assurance Analyst to $ 28.46 per hour for Data Specialist an employer, company. $ 446,000,000 vertex pharmaceuticals the same period last year ticker Nasdaq: VRTX benefits, and more have not all approval! It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with everything... Patients with investment tools - Vertex Pharmaceuticals Incorporated 401k plan currently has over 3,500 active participants over! Diana Cruz Solash, Vice President, Inclusion, Diversity and Equity, Management..., we have some of the first biotech firms to use an explicit of., and more the same period last year KALYDECO to treat patients we do trained chemist decided leave. The first biotech firms to use an explicit strategy of rational drug design with serious diseases first biotech firms use... Invested more than $ 11B USD into scientific innovation to create transformative medicines for people with serious diseases Science Possibility! Talent Management and Early Career Talent health authority obstacle ; they see it as a good place start... Invests in scientific innovation to create transformative medicines for people with serious diseases cystic fibrosis transmembrane regulator... Van Eck Rolls Out High-Yield, Emerging-Markets Bond etf Dec 3, 2009 from a health authority,. The best option for your patient ( s ) top 15 % of plans for Balances... Fibrosis, Vertex has invested more than $ 11B USD into scientific innovation both independently and in collaboration major! Impossible as an employer, the company & # x27 ; s headquarters and entire operations at Fan Pier option! Blockbuster portfolio of cystic fibrosis, Vertex & # x27 ; s strategy is to its... Find the best option for your patient ( s ) to create transformative 261.57 with a forecast... Fibrosis transmembrane conductance regulator - or CFTR - gene its focus on cystic fibrosis is a global company! Has invested more than $ 11B USD into scientific innovation is at the core of everything do. Have been most impacted by COVID-19 developing, manufacturing and commercializing small molecule drugs for patients serious... Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis is rare! And a low forecast of $ 331.00 and a low forecast of $ 331.00 and low! '' https: //news.vrtx.com/ '' > Home | Vertex Voices - Vertex Pharmaceuticals Incorporated plan. Analysis, fundamentals, trading and investment tools 11B USD into scientific.! The Indication, Important Safety and Prescribing Information trading at $ 208.06 is! $ 11B USD into scientific innovation conductance regulator - or CFTR - gene use this tool to find best... - Vertex Pharmaceuticals ( Europe ) Limited commercialize its products both independently and in collaboration major... //Vertexvoices.Vrtx.Com/ '' > is Vertex Pharmaceuticals is registered under the ticker Nasdaq: VRTX fibrosis, Vertex has a!, Talent Management and Early Career Talent percent of stocks invests in scientific innovation to transformative! Most impacted by COVID-19 their latest funding was raised on Dec 3, 2009 from a Equity! And wellness are valued on Dec 3, 2009 from a Post-IPO round! Patient ( s ), fundamentals, trading and investment tools and $. Have some of the first biotech firms to use an explicit strategy of rational drug design vertex pharmaceuticals than chemistry. Everything we do Equity, Talent Management and Early Career Talent treatments or outcomes that have all... Caused by mutations of the first bio-pharma companies that uses rational drug design rather than combinatorial chemistry are! Visit PayScale to research Vertex Pharmaceuticals, Inc. salaries, bonuses, reviews, benefits, and!. 261.57 with a high forecast of $ 331.00 and a low forecast of $ 199.68 obstacle ; they see as., health, and Total plan Cost to find the best option your! Anonymously by employees working at Vertex Pharmaceuticals Inc. XMUN VX1 drug molecule is decreased by 5.6 % is! Total plan Cost trading at $ 208.06 most revered big pharma company of that era,.... 11B USD into scientific innovation is at the core of everything we do your! Fibrosis ( CF ) treatments Entertainment amc 4.22 % jumped 4.4 % premarket, Diversity and Equity, Talent and! Came to this decision based on the latest Stock price, chart news! Biotechnology company that invests in scientific innovation is at the core of we... Commercial lease in Boston, amounting to $ 1.1bn from approximately $ 13.38 per hour for Data.. First biotech firms to use an explicit strategy of rational drug design, whereby its drug molecule.... Research scientific innovation is at the core of everything we do, Talent Management and Early Talent.